Aridis Pharmaceuticals (ARDS)

Last Closing Price: 0.31 (2023-07-18)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Aridis Pharmaceuticals (ARDS) had Net Income of $-30.37M for the most recently reported fiscal year, ending 2022-12-31.

Figures for fiscal year ending 2022-12-31
Income Statement Financials
$3.09M
Net Income
$-30.37M
--
$3.09M
$33.08M
$-29.99M
$-0.38M
$-30.37M
$-30.37M
$-30.37M
$-30.37M
$-30.37M
$-30.37M
$-29.99M
$-29.51M
18.78M
18.78M
$-1.62
$-1.62
Balance Sheet Financials
$11.63M
$0.73M
$3.07M
$14.70M
$36.90M
--
$2.03M
$38.93M
$-24.23M
$-24.25M
$-24.23M
27.03M
Cash Flow Statement Financials
$-29.13M
$-0.08M
$14.78M
$19.99M
$5.56M
$-14.43M
$1.48M
--
--
Fundamental Metrics & Ratios
0.32
--
--
--
-0.18
100.00%
-970.33%
-970.33%
-954.58%
-982.56%
-982.56%
$-29.21M
--
--
--
0.21
--
2.49
146.43
125.33%
125.25%
-206.68%
125.33%
$-0.90
$-1.56
$-1.55